GX CG5
Generic Name: lamivudine
Pill imprint GX CG5 has been identified as Epivir HBV 100 mg.
Epivir-HBV is used in the treatment of hiv infection; hepatitis b; nonoccupational exposure; occupational exposure and belongs to the drug class nucleoside reverse transcriptase inhibitors (NRTIs). Risk cannot be ruled out during pregnancy.
Epivir-HBV 100 mg is not subject to the Controlled Substances Act.
See also related documents.
Epivir HBV Images
- Generic Name:
- lamivudine
- Imprint:
-
GX CG5
- Strength:
- 100 mg
- Color:
- Yellow
- Shape:
- Capsule-shape
- Availability:
- Prescription only
- Inactive Ingredients:
- hypromelloses
polyethylene glycol
magnesium stearate
microcrystalline cellulose
polysorbate 80
ferric oxide red
sodium starch glycolate type A potato
titanium dioxide
ferric oxide yellow
- Drug Class:
- Nucleoside reverse transcriptase inhibitors (NRTIs)
- Pregnancy Category:
- C - Risk cannot be ruled out
- CSA Schedule:
- N - Not a controlled drug
- Manufacturer:
- GlaxoSmithKline
- National Drug Code (NDC):
- 00173-0662
| NDC Code | Manufacturer / Repackager |
|---|---|
| 68258-9107 | Dispensing Solutions Inc. (repackager) |
Note: Inactive ingredients may vary.
More Epivir HBV resources
- Epivir-HBV (Wolters Kluwer)
- Epivir-HBV Solution (Wolters Kluwer)
- Epivir HBV (Cerner Multum)
- Epivir HBV (Micromedex) - Includes Dosage Information
- Epivir-HBV (FDA)


